NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Ambuja Cement Research Report

Company Overview Ambuja Cement, a leading cement manufacturer, operates one of its largest integrated cement facilities at Sanghipuram in Kutch, Gujarat. The facility boasts a cement/clinker capacity of 6.1mtpa/6.6mtpa, supported by 1Bt of high-quality limestone reserves.

Capacity Expansion and Capex The company has indicated that its current operational cement capacity of 17,000tpd can increase by 2,500tpd through debottlenecking, taking capacity to 20,000tpd (7mtpa). Ambuja Cement has planned a Rs6bn capex focused on efficiency improvements, including the installation of a Waste Heat Recovery System (WHRS) with a capacity of 18MW.

Logistics and Cost Competitiveness The Sanghipuram plant benefits from coastal logistics through its jetty, enabling clinker and cement movement to markets such as Tuticorin, Dahej, and Mumbai. This results in logistics costs of Rs700/t, compared to the pan-India average of Rs900/t. The plant also has a 130MW captive power capacity, supporting cost competitiveness.

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

Outlook and Recommendations We remain constructive on Ambuja Cement's long-term growth prospects, given its initiatives on improving cost efficiencies and ongoing expansion strategy. We maintain a BUY rating with a Target Price (TP) of Rs640, valuing the company at 17x EV/Mar'27E EBITDA. At the current market price, the stock is trading at 12.5x/10.7x EV on FY27E/28E EBITDA.

Investor Takeaway

Investors should consider Ambuja Cement's potential for growth and cost reductions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.